Investigating heart function in patients with a HeartMate 3 device
Official title: Exploration of Intracardiac Geometry and Hemodynamics During HeartMate 3 Therapy: A Novel Approach Using Photon-Counting CT and Computational Fluid Dynamics
Run by Region Östergötland · NCT06115096 · Data updated 2026-11-12
This study is testing how changing the flow levels in the HeartMate 3 device affects heart function and blood flow in patients with heart failure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 35 (estimated) |
| Sponsor | Region Östergötland Academic / other |
| Locations | 1 site (Linköping, Östergötland County) |
| Status | Recruiting |
| Started | March 1, 2023 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2030 |
| Registry record updated | November 2, 2023 |
| Trial ID | NCT06115096 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who have been treated with the HeartMate 3 device for more than six months.
✕Probably not a fit
Patients with reduced kidney function, known iodine contrast allergy, untreated hyperthyroidism, or certain other medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore how different flow levels in the HeartMate 3 left ventricular assist device affect intracardiac geometry and hemodynamics in patients with heart failure. Participants will undergo three photon-counting CT scans and echocardiographic imaging in a single session, while their HeartMate device's flow is varied. The study will analyze three-dimensional geometry and computational fluid dynamics parameters, including blood velocity and pressure, in relation to device settings and patient characteristics. The findings could enhance understanding of cardiac function during mechanical circulatory support.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and management of heart failure patients using the HeartMate 3 device.
How similar studies have gone: While the use of advanced imaging techniques in this context is relatively novel, previous studies have shown promise in improving hemodynamic monitoring in heart failure patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Connected to Linköping University Hospital ((situated in the Swedish Southeastern healthcare region) * Treatment with HeartMate 3 and implanted for \> 6 months ago * Age \>18 years. Exclusion Criteria: * Reduced kidney function (eGFR below 45 ml/min/1.73m2). * Known iodine contrast allergy * In case of untreated manifest hyperthyroidism * In case of suspected/newly diagnosed thyroid cancer where radioiodine examination/treatment may be relevant * Myasthenia Gravis * Ongoing pregnancy
Where it's running
-
Linköping University Hospital
Linköping, Östergötland County, Sweden Recruiting
Study contacts
- Principal investigator: Hans Granfeldt, MD/PhD — Region Östergötland
- Study coordinator: Hans Granfeldt, MD/PhD
- Email: hans.granfeldt@regionostergotland.se
- Phone: 010-103 00 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.